SOLIGENIX, INC. Net Income (Loss) Available to Common Stockholders, Basic
SOLIGENIX, INC. (SNGX) reported Net Income (Loss) Available to Common Stockholders, Basic of -$1.99 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-07
- SOLIGENIX, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was -$1.99M.
- SOLIGENIX, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$2.82M.
- SOLIGENIX, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was -$2.90M.
- SOLIGENIX, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$2.53M.
- SOLIGENIX, INC. net income (loss) available to common stockholders, basic for fiscal 2025 was -$11.08M.
- SOLIGENIX, INC. net income (loss) available to common stockholders, basic for fiscal 2024 was -$8.27M.
- SOLIGENIX, INC. net income (loss) available to common stockholders, basic for fiscal 2023 was -$6.14M.
- SOLIGENIX, INC. net income (loss) available to common stockholders, basic for fiscal 2022 was -$13.80M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$1.99M 10-Q · filed 2026-08-07 | -$4.81M 10-Q · filed 2026-08-07 | -$7.71M derived: sum of 3 quarters · filed 2026-08-07 | -$10.24M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | -$2.82M 10-Q · filed 2026-05-08 | -$5.72M derived: sum of 2 quarters · filed 2026-05-08 | -$8.25M derived: sum of 3 quarters · filed 2026-05-08 | -$10.95M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | -$2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$5.43M derived: sum of 2 quarters · filed 2026-03-31 | -$8.13M derived: sum of 3 quarters · filed 2026-08-07 | -$11.08M 10-K · filed 2026-03-31 | |
| 2025-09-30 | -$2.53M 10-Q · filed 2025-11-07 | -$5.23M derived: sum of 2 quarters · filed 2026-08-07 | -$8.18M 10-Q · filed 2025-11-07 | -$11.17M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | -$2.70M 10-Q · filed 2026-08-07 | -$5.65M 10-Q · filed 2026-08-07 | -$8.64M derived: sum of 3 quarters · filed 2026-08-07 | -$10.36M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | -$2.95M 10-Q · filed 2026-05-08 | -$3.24M 10-Q · filed 2025-05-09 | -$5.94M derived: sum of 2 quarters · filed 2026-05-08 | -$7.66M derived: sum of 3 quarters · filed 2026-05-08 | -$9.30M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$2.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$4.71M derived: sum of 2 quarters · filed 2026-03-31 | -$6.35M derived: sum of 3 quarters · filed 2026-03-31 | -$8.27M 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$1.72M 10-Q · filed 2025-11-07 | -$3.36M derived: sum of 2 quarters · filed 2025-11-07 | -$5.28M 10-Q · filed 2025-11-07 | -$7.10M derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | -$1.64M 10-Q · filed 2025-08-14 | -$3.56M 10-Q · filed 2025-08-14 | -$5.38M derived: sum of 3 quarters · filed 2025-08-14 | -$7.04M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | -$1.92M 10-Q · filed 2025-05-09 | -$3.74M derived: sum of 2 quarters · filed 2025-05-09 | -$5.40M derived: sum of 3 quarters · filed 2025-05-09 | -$7.01M derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | -$1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -$3.48M derived: sum of 2 quarters · filed 2025-03-21 | -$5.09M derived: sum of 3 quarters · filed 2025-03-21 | -$6.14M 10-K · filed 2025-03-21 | |
| 2023-09-30 | -$1.66M 10-Q · filed 2024-11-08 | -$3.27M derived: sum of 2 quarters · filed 2024-11-08 | -$4.32M 10-Q · filed 2024-11-08 | -$8.07M derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | -$1.61M 10-Q · filed 2024-08-09 | -$2.66M 10-Q · filed 2024-08-09 | -$6.41M derived: sum of 3 quarters · filed 2024-08-09 | -$9.72M derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | -$1.05M 10-Q · filed 2024-05-10 | -$4.80M derived: sum of 2 quarters · filed 2024-05-10 | -$8.11M derived: sum of 3 quarters · filed 2024-05-10 | -$10.50M derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | -$3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$7.06M derived: sum of 2 quarters · filed 2024-03-15 | -$9.45M derived: sum of 3 quarters · filed 2024-03-15 | -$13.80M 10-K · filed 2024-03-15 | |
| 2022-09-30 | -$3.31M 10-Q · filed 2023-11-13 | -$5.70M derived: sum of 2 quarters · filed 2023-11-13 | -$10.04M 10-Q · filed 2023-11-13 | -$14.75M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$2.39M 10-Q · filed 2023-08-21 | -$6.74M 10-Q · filed 2023-08-21 | -$11.44M derived: sum of 3 quarters · filed 2023-08-21 | -$15.03M derived: sum of 4 quarters · filed 2023-08-21 | |
| 2022-03-31 | -$4.35M 10-Q · filed 2023-05-15 | -$9.05M derived: sum of 2 quarters · filed 2023-05-15 | -$12.64M derived: sum of 3 quarters · filed 2023-05-15 | -$14.54M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$8.29M derived: sum of 2 quarters · filed 2023-03-31 | -$10.19M derived: sum of 3 quarters · filed 2023-03-31 | -$12.55M 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$3.59M 10-Q · filed 2022-11-10 | -$5.48M derived: sum of 2 quarters · filed 2022-11-10 | -$7.85M 10-Q · filed 2022-11-10 | -$13.39M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | -$1.90M 10-Q · filed 2022-08-12 | -$4.26M 10-Q · filed 2022-08-12 | -$9.80M derived: sum of 3 quarters · filed 2022-08-12 | -$11.59M derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | -$2.36M 10-Q · filed 2022-05-13 | -$7.90M derived: sum of 2 quarters · filed 2022-05-13 | -$9.69M derived: sum of 3 quarters · filed 2022-05-13 | -$12.47M derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | -$5.54M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$7.33M derived: sum of 2 quarters · filed 2022-03-29 | -$10.11M derived: sum of 3 quarters · filed 2022-03-29 | -$17.69M 10-K · filed 2022-03-29 | |
| 2020-09-30 | -$1.79M 10-Q · filed 2021-11-12 | -$4.57M derived: sum of 2 quarters · filed 2021-11-12 | -$12.15M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | -$2.78M 10-Q · filed 2021-08-13 | -$10.36M 10-Q · filed 2021-08-13 | |||
| 2017-12-31 | -$2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$3.10M derived: sum of 2 quarters · filed 2018-03-15 | -$5.41M derived: sum of 3 quarters · filed 2018-03-15 | -$7.15M 10-K · filed 2018-03-15 | |
| 2017-09-30 | -$963.09K 10-Q · filed 2017-11-06 | -$3.27M derived: sum of 2 quarters · filed 2017-11-06 | -$5.01M 10-Q · filed 2017-11-06 | -$5.34M derived: sum of 4 quarters · filed 2018-03-15 | |
| 2017-06-30 | -$2.31M 10-Q · filed 2017-08-11 | -$4.05M 10-Q · filed 2017-08-11 | -$4.37M derived: sum of 3 quarters · filed 2018-03-15 | -$6.05M derived: sum of 4 quarters · filed 2018-03-15 | |
| 2017-03-31 | -$1.73M 10-Q · filed 2017-05-11 | -$2.06M derived: sum of 2 quarters · filed 2018-03-15 | -$3.74M derived: sum of 3 quarters · filed 2018-03-15 | -$3.83M derived: sum of 4 quarters · filed 2018-03-15 | |
| 2016-12-31 | -$329.96K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$2.00M derived: sum of 2 quarters · filed 2018-03-15 | -$2.10M derived: sum of 3 quarters · filed 2018-03-15 | -$3.25M 10-K · filed 2018-03-15 | |
| 2016-09-30 | -$1.67M 10-Q · filed 2017-11-06 | -$1.77M derived: sum of 2 quarters · filed 2017-11-06 | -$2.92M 10-Q · filed 2017-11-06 | -$4.97M derived: sum of 4 quarters · filed 2017-11-06 | |
| 2016-06-30 | -$92.78K 10-Q · filed 2017-08-11 | -$1.24M 10-Q · filed 2017-08-11 | -$3.30M derived: sum of 3 quarters · filed 2017-08-11 | -$526.42K derived: sum of 4 quarters · filed 2017-08-11 | |
| 2016-03-31 | -$1.15M 10-Q · filed 2017-05-11 | -$3.21M derived: sum of 2 quarters · filed 2017-05-11 | -$433.65K derived: sum of 3 quarters · filed 2017-05-11 | -$4.41M derived: sum of 4 quarters · filed 2017-05-11 | |
| 2015-12-31 | -$2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | $715.79K derived: sum of 2 quarters · filed 2017-03-27 | -$3.26M derived: sum of 3 quarters · filed 2017-03-27 | -$7.83M 10-K · filed 2017-03-27 | |
| 2015-09-30 | $2.77M 10-Q · filed 2016-11-10 | -$1.20M derived: sum of 2 quarters · filed 2016-11-10 | -$5.77M 10-Q · filed 2016-11-10 | -$3.85M derived: sum of 4 quarters · filed 2016-11-10 | |
| 2015-06-30 | -$3.98M 10-Q · filed 2016-08-11 | -$8.55M 10-Q · filed 2016-08-11 | -$6.62M derived: sum of 3 quarters · filed 2016-08-11 | -$10.97M derived: sum of 4 quarters · filed 2016-08-11 | |
| 2015-03-31 | -$4.57M 10-Q · filed 2016-05-12 | -$2.65M derived: sum of 2 quarters · filed 2016-05-12 | -$7.00M derived: sum of 3 quarters · filed 2016-05-12 | ||
| 2014-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-24 | -$2.43M derived: sum of 2 quarters · filed 2016-03-24 | -$6.71M 10-K · filed 2016-03-24 | ||
| 2014-09-30 | -$4.35M 10-Q · filed 2015-11-12 | -$8.63M 10-Q · filed 2015-11-12 | |||
| 2013-12-31 | -$10.06M 10-K · filed 2015-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |